Announce Date | 03/11/2025 |
EPS Normalized Actual | $-0.57 (Beat by $0.05) |
EPS GAAP Actual | $-0.57 (Beat by $0.05) |
Revenue Actual | $0B |
Revenue Surprise | Beat by $0M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $-0.8 |
EPS GAAP Estimate | $-0.8 |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | -5.985 | -1.51 | -5.985 | -5.985 | 1 |
Dec 2028 | -7.05 | -1.28 | -7.05 | -7.05 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | -0.57 | 0.025 | 0B | NAN% | 0M |
FQ3 2023 (Sep 2023) | -0.36 | -0.36 | 0B | NAN% | 0M |
FQ4 2023 (Dec 2023) | 0 | 0 | 0B | NAN% | 0M |
FQ3 2024 (Sep 2024) | -0.5 | 0.035 | 0B | NAN% | 0M |
FQ2 2023 (Jun 2023) | -0.18 | -0.18 | 0B | NAN% | 0M |
FQ2 2024 (Jun 2024) | -0.5 | 0.1 | 0B | NAN% | 0M |
FQ1 2023 (Mar 2023) | -0.17 | -0.17 | 0B | NAN% | 0M |
FQ1 2024 (Mar 2024) | -0.64 | -0.64 | 0B | NAN% | 0M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
-0.8
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | -1.28 | -- | -1.28 | -1.28 | 1 |
FQ3 2026 (Sep 2026) | -1.24 | -- | -1.24 | -1.24 | 1 |
FQ2 2026 (Jun 2026) | -0.97 | -- | -0.97 | -0.97 | 1 |
FQ1 2026 (Mar 2026) | -0.98 | -- | -0.98 | -0.98 | 1 |
FQ4 2025 (Dec 2025) | -0.81 | 29.63 | -0.81 | -0.81 | 1 |
FQ3 2025 (Sep 2025) | -0.76 | 34.21 | -0.76 | -0.76 | 1 |
FQ2 2025 (Jun 2025) | -0.8 | 37.5 | -0.8 | -0.8 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 0B | -- | 0B | 0B | 0 |
FQ3 2026 (Sep 2026) | 0B | -- | 0B | 0B | 0 |
FQ2 2026 (Jun 2026) | 0B | -- | 0B | 0B | 0 |
FQ1 2026 (Mar 2026) | 0B | -- | 0B | 0B | 0 |
FQ4 2025 (Dec 2025) | 0B | -- | 0B | 0B | 0 |
FQ3 2025 (Sep 2025) | 0B | -- | 0B | 0B | 0 |
FQ2 2025 (Jun 2025) | 0B | -- | 0B | 0B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
4
EPS # of in-lines
1
Revenue # of Beats
0
Revenue # of Misses
0
Revenue # of in-lines
8
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | -0.595 | -0.57 | 0.025 | -4.39% |
FQ3 2023 (Sep 2023) | -0.36 | -0.36 | 100% | |
FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
FQ3 2024 (Sep 2024) | -0.535 | -0.5 | 0.035 | -7% |
FQ2 2023 (Jun 2023) | -0.18 | -0.18 | 100% | |
FQ2 2024 (Jun 2024) | -0.6 | -0.5 | 0.1 | -20% |
FQ1 2023 (Mar 2023) | -0.17 | -0.17 | 100% | |
FQ1 2024 (Mar 2024) | -0.64 | -0.64 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $0B | $0M | NAN% |
FQ3 2023 (Sep 2023) | $0B | $0B | $0M | NAN% |
FQ4 2023 (Dec 2023) | $0B | $0B | $0M | NAN% |
FQ3 2024 (Sep 2024) | $0B | $0B | $0M | NAN% |
FQ2 2023 (Jun 2023) | $0B | $0B | $0M | NAN% |
FQ2 2024 (Jun 2024) | $0B | $0B | $0M | NAN% |
FQ1 2023 (Mar 2023) | $0B | $0B | $0M | NAN% |
FQ1 2024 (Mar 2024) | $0B | $0B | $0M | NAN% |